Welcome to our dedicated page for Viatris Ord Shs SEC filings (Ticker: VTRS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Viatris Inc. (Nasdaq: VTRS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents help investors understand how Viatris reports its financial performance, governance decisions and key corporate events as a global healthcare company that bridges generics and brands.
Viatris regularly files current reports on Form 8‑K to announce material events such as quarterly financial results, changes to bylaws, board appointments and other significant corporate actions. For example, the company has used Form 8‑K to report results for periods ended June 30 and September 30, 2025, and to disclose amendments to its bylaws related to proxy access and annual meeting timing. These filings often reference accompanying press releases that provide additional detail.
The company’s proxy statement on Schedule 14A (DEF 14A) offers insight into governance, board composition, executive compensation and strategic priorities. In its definitive proxy statement, Viatris discusses its enterprise-wide strategic review, capital return plans, pipeline progress and long-term shift toward a greater share of innovative brands, giving shareholders context for voting decisions and for evaluating management’s plans.
On this page, users can also monitor other SEC forms that may appear over time, such as annual and quarterly reports or any insider transaction reports on Form 4, as they become available. Stock Titan enhances these filings with AI-powered summaries that highlight key points, explain technical language and help readers quickly identify topics such as revenue trends, strategic initiatives, bylaw changes and risk factors relevant to Viatris’ pharmaceutical preparation manufacturing business.
Filings are updated as they are released through EDGAR, allowing investors, analysts and other stakeholders to follow how Viatris communicates its financial condition, governance framework and strategic evolution through official regulatory channels.
Viatris Inc director Leo Frans Groothuis reported routine equity compensation activity. Restricted stock units and related dividend equivalent units that were previously granted vested and were exercised into common stock on
On the same date, Groothuis received a new grant of 15,890 restricted stock units, each representing one future share of Viatris common stock that will vest on
Viatris Inc director David S. Simmons reported compensation-related equity activity and small prior share purchases. On March 6, 2026, 22,820 restricted stock units and 523.0399 dividend equivalent units vested and were settled into 23,344 shares of common stock, with fractional shares rounded up under the RSU award terms. On the same date, he received a new grant of 15,890 restricted stock units that will vest on March 6, 2027, each RSU representing one common share.
The filing also shows earlier open-market purchases by family trusts associated with Simmons in 2025, totaling 499 shares of common stock at prices around $10.42 per share. According to the footnotes, these trust purchases were executed by investment advisors in managed accounts designed to mirror certain index funds.
Viatris Inc director James M. Kilts reported compensation-related equity transactions with no share sales. On March 6, 2026 he exercised 23,660 restricted stock units and 1,174.4921 dividend equivalent units, receiving 24,834.4921 shares of common stock. He also received a new grant of 15,890 restricted stock units that will vest on March 6, 2027. Following these acquisitions, he directly holds 161,257 shares of common stock and 15,890 unvested restricted stock units. All activity reflects awards under the Viatris Inc. 2020 Stock Incentive Plan.
Viatris Inc director Dillon JoEllen Lyons reported equity compensation activity involving restricted stock units and common shares. On March 6, 2026, previously granted RSUs and related dividend equivalent units representing a total of 24,834.4921 units were exercised, delivering the same number of common shares as they vested in full.
On the same date, Lyons received a new grant of 15,890 RSUs, each representing one future share of Viatris common stock that will vest on March 6, 2027. Following these transactions, she directly holds 102,526 shares of common stock and indirectly holds an additional 18 shares through her spouse.
Viatris Inc director Vivaldi Coelho Rogerio reported equity compensation activity involving restricted stock units (RSUs) and related common shares. On March 6, 2026, previously granted RSUs representing 23,660 shares of common stock vested in full and were exercised, along with 1,174.4921 dividend equivalent units that had accrued on those RSUs. These derivative securities converted into common stock, leaving no remaining balance from those specific RSUs or dividend units.
On the same date, the director received a new grant of 15,890 RSUs, each representing one share of Viatris common stock, which will vest on March 6, 2027. Following these transactions, the filing shows 46,526 shares of common stock held directly and a separate outstanding RSU award of 15,890 units scheduled to vest in 2027. The activity reflects routine vesting and a new equity award rather than any open-market buying or selling.
DAMELIO FRANK A reported acquisition or exercise transactions in this Form 4 filing.
Viatris Inc director Frank A. Damelio reported routine equity compensation activity. On March 6, 2026, previously granted restricted stock units (RSUs), including related dividend equivalent units, were fully settled into 26,031 shares of common stock that he now holds directly.
On the same date, he also received a new grant of 15,890 RSUs, each representing one future share of Viatris common stock. According to the award terms, these new RSUs will vest on March 6, 2027, reflecting ongoing director compensation rather than open-market buying or selling.
Viatris Inc director W. Don Cornwell increased his equity stake through routine equity awards and vesting. On March 6, 2026 he exercised 23,660 restricted stock units and 1,174.4921 dividend equivalent units into 23,660 and 1,175 shares of common stock, respectively. He also received a new grant of 15,890 restricted stock units that will vest on March 6, 2027.
Following these transactions, he directly holds 112,044 shares of Viatris common stock and 15,890 restricted stock units, reflecting compensation-related activity rather than open-market buying or selling.
Viatris Inc director Elisha W. Finney reported equity compensation activity, not open-market trading. On March 6, 2026, Finney exercised restricted stock units and related dividend equivalent units, acquiring 24,834.4921 shares of Viatris common stock through derivative conversions.
After these settlements, Finney directly held 62,667 shares of common stock. On the same date, Finney also received a new grant of 15,890 restricted stock units under the Viatris Inc. 2020 Stock Incentive Plan, which will vest on March 6, 2027.
Viatris Inc director David S. Simmons filed an amended ownership report showing indirect holdings of 684 shares of common stock held through family trusts. These include 13 shares in a trust for his benefit, 63 shares in a trust for him and his children, 522 shares in a trust for his spouse, and 86 shares in trusts for his children. The filing updates how these indirect, trust-held shares are reported rather than detailing any new stock purchase or sale.
Viatris Inc Chief Financial Officer Theodora Mistras reported equity award activity tied to previously granted restricted stock units. On March 4, 2026, restricted stock units and related dividend equivalent units granted on March 4, 2024 vested and were converted into shares of common stock.
She acquired 31,149 shares of common stock from RSUs and 2,935 shares from dividend equivalent units through exercises at